 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. Centers for Disease Control and Prevention
• News Briefs
Bristol-Myers Squibb Applies to Sell New AIDS Drug in EuropeMay 30, 2002 This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document. Bristol-Myers Squibb said Wednesday it has applied to the European equivalent of the US Food and Drug Administration for clearance to market and sell Atazanavir, a drug currently in development for the treatment of HIV/AIDS. The drug is a viral protease inhibitor that has shown potential for once-daily use, Bristol scientists said. Trials have included more than 1,500 patients whose conditions run the spectrum of HIV infection.
Back to other CDC news for May 30, 2002 This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document. Associated Press 05.29.02 This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
E-Mail
Printable Single-Page
Glossary
Share
